Abiopharma

🔍 KENNEDY DOUGLAS L (Executive)

Company: PEAPACK GLADSTONE FINANCIAL CORP (PGC)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Acquired 3,896 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 43,024.75 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,993 shares of Common Stock at $33.18 per share (Direct)
  Date: 2026-03-20 | Code: F | equity_swap_involved: false | shares_owned_after: 41,031.75 | transaction_form_type: 4 | Footnotes: F2
• Acquired 3,494 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 44,525.75 | transaction_form_type: 4 | Footnotes: F3
• Sold 1,788 shares of Common Stock at $33.18 per share (Direct)
  Date: 2026-03-20 | Code: F | equity_swap_involved: false | shares_owned_after: 42,737.75 | transaction_form_type: 4 | Footnotes: F2
• Acquired 3,674 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 212,533.00 | transaction_form_type: 4 | Footnotes: F4, F5
• Acquired 18,097 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 230,630.00 | transaction_form_type: 4 | Footnotes: F6, F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: H | nature_of_ownership: 401(k) | shares_owned_after: 18,621.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: H | nature_of_ownership: Employee Stock Purchase Plan | shares_owned_after: 10,893.34
• Sold 3,896 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 7,793.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1
• Acquired 16,150 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: A | equity_swap_involved: false | shares_owned_after: 16,150.00 | transaction_form_type: 4 | Footnotes: F7, F7, F7, F7
• Sold 3,674 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 3,678.00 | transaction_form_type: 4 | Footnotes: F4, F4, F4, F4
• Sold 3,494 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 6,990.00 | transaction_form_type: 4 | Footnotes: F3, F3, F3, F3
• Sold 18,097 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F6, F6, F6, F6
• Acquired 24,225 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: A | equity_swap_involved: false | shares_owned_after: 24,225.00 | transaction_form_type: 4 | Footnotes: F9, F9, F9, F9
• Sold 3,440 shares of Phantom Stock (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 3,441.00 | transaction_form_type: 4 | Footnotes: F10, F10, F10, F10
• Acquired 2,828 shares of Phantom Stock (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F11, F11, F11, F11
• Holds 17,534 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: H | shares_owned_after: 17,534.00 | Footnotes: F8, F8, F8
• Holds 0 shares of Phantom Stock (Derivative)
  Date: 2026-03-20 | Code: H | shares_owned_after: 15,482.00 | Footnotes: F12, F12, F12, F12

Footnotes:

• F1: On March 20, 2025, the reporting person was granted 11,689 restricted stock units (RSUs), vesting in three equal annual installments beginning on March 20, 2026. Upon vesting, each RSU converts into one share of PGC common stock.
• F2: Shares withheld to satisfy tax withholding obligations arising from settlement of restricted stock units.
• F3: On March 20, 2023, the reporting person was granted 17,472 restricted stock units (RSUs), vesting in five equal annual installments beginning on March 20, 2024. Upon vesting, each RSU converts into one share of PGC common stock.
• F4: On March 20, 2022, the reporting person was granted 18,374 restricted stock units (RSUs), vesting in five equal annual installments beginning on March 20, 2024. Upon vesting, each RSU converts into one share of PGC common stock.
• F5: Held indirectly through a rabbi trust pursuant to a non-qualified deferred compensation plan.
• F6: On March 20, 2023, the reporting person was granted 26,208 restricted stock units (RSUs), vesting on the third anniversary of the grant if certain performance conditions are met. Upon vesting, each RSU converts into one share of PGC common stock. 18,097 restricted stock units vested.
• F7: On March 20, 2026, the reporting person was granted 16,150 restricted stock units (RSUs), vesting in three equal annual installments beginning on March 20, 2027. Upon vesting, each RSU converts into one share of PGC common stock.
• F8: On March 20, 2025, the reporting person was granted 17,534 restricted stock units (RSUs), vesting on the third anniversary of the grant if certain performance conditions are met. Upon vesting, each RSU converts into one share of PGC common stock.
• F9: On March 20, 2026, the reporting person was granted 24,225 restricted stock units (RSUs), vesting on the third anniversary of the grant if certain performance conditions are met. Upon vesting, each RSU converts into one share of PGC common stock.
• F10: On March 20, 2024, the reporting person was granted 10,321 phantom stock shares, vesting in three equal annual installments beginning on March 20, 2025. Upon vesting, each phantom share is the economic equivalent of one share of common stock.
• F11: On March 20, 2021, the reporting person was granted 14,127 phantom stock shares, vesting in five equal annual installments beginning on March 20, 2022. Upon vesting, each phantom share is the economic equivalent of one share of common stock.
• F12: On March 20, 2024, the reporting person was granted 15,482 phantom stock shares, vesting on the third anniversary of the grant if certain performance conditions are met. Upon vesting, each phantom share is the economic equivalent of one share of common stock.